Policy & governance of innovative technologies

Regulations, standards and guidelines to ensure safety, quality and efficacy are an integral part of the development of technological advances, particularly in life sciences. Innogen’s research on the governance systems we adopt for innovative technologies, how such choices are made and their impact on future innovation trajectories, the fate of future sectors of the economy, and the competitive advantage of nations, is internationally unique.

Projects

Creative states: Is state-led risk-taking the answer to post-Covid-19 recovery?

28 April 2021

Writing in the RSA Journal, Innogen Director, Theo Papaioannou, examines how the entrepreneurial state could work in practice.

Call for abstracts: European Forum for Studies of Policies for Research and Innovation 2022 conference

14 January 2022

This year’s Eu-SPRI 2022 conference “Challenging Science and Innovation Policy” will take place 1-3 June in Utrecht, the Netherlands. Innogen Director Theo Papaioannou and Lukas Fuchs at Eindhoven University of Technology are organising a special session on the ethics and politics of science, technology & innovation policy. Abstracts for this session should be submitted by the 15th February.

Innogen annual meeting 2022

13 June 2022

Innogen researchers and PhD students at The Open University and The University of Edinburgh gathered at High School Yards Teaching Centre in Edinburgh on the 26-27th May to present their work and share future plans.

In Conversation event: Why is drug R&D so much less efficient now than it was in 1950?

16 March 2023

On the 2nd of February, Dr Farah Huzair, Lecturer in Science, Technology and Innovation Studies, at The University of Edinburgh's School of Social and Political Sciences, and Dr Jack Scannell, CEO of Etheros Pharmaceuticals and Innogen Associate, discussed the reasons underlying the marked decline in drug R&D output efficiency since 1950 and ways to improve it.